Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma
一项随机II期研究比较了两种剂量的瑞戈非尼在晚期肝细胞癌二线治疗中的疗效
期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2025.101509
Koroki, Keisuke; Ogasawara, Sadahisa; Yumita, Sae; Nakagawa, Miyuki; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Suzuki, Eiichiro; Ooka, Yoshihiko; Nakamoto, Shingo; Shiko, Yuki; Ozawa, Yoshihito; Inaba, Yosuke